GI Cancers

ctDNA and Its Role in Hepatocellular Carcinoma

Tanios S. Bekaii-Saab, MD
Emerging Role of Fibroblast Growth Factor Receptor 2b (FGFR2b) Inhibitors in Gastroesophageal Cancers

Tanios S. Bekaii-Saab, MD
Implementing HER2-Targeted Strategies for the Treatment of Biliary Tract Cancers

John Strickler, MD; Tanios S. Bekaii-Saab, MD
NRG1 Fusions: The Newest Actionable Target

John Strickler, MD
Recent Advances in the Management of Advanced Hepatocellular Cancer

Tanios S. Bekaii-Saab, MD
Management of HER2 + Biliary Tract Cancers

Shubham Pant, MD, MBBS
Shifting Landscape in the Treatment of Biliary Tract Cancers: The Role of Immunotherapy and Other Targeted Therapies

Tanios S. Bekaii-Saab, MD
Improving Survival Outcomes in HCC and the Role of Immunotherapies

Tanios S. Bekaii-Saab, MD
The Role of IO Based Therapy in Patients with HCC: An All Stage Strategy?

Tanios S. Bekaii-Saab, MD
NTRK Mutated Pancreatic Cancer

Martin F. Dietrich, MD, PhD